EUVIMEDEUVIMED entdecken
Crossref

Regorafenib Induced Toxic Erythema of Chemotherapy Presenting as Malignant Intertigo with Hand Foot Skin Reaction

Mehta Ambalal S

Clinical Dermatology Open Access Journal · 2017

DOI: 10.23880/cdoaj-16000134 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Dermatology Open Access Journal, 2017. Verfasst von Mehta Ambalal S.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Newer chemotherapeutic drugs often present with adverse reactions involving the skin.These reactions may be mistaken for infections, drug allergies or GVHD.Regorafenib is a multikinase inhibitor with a characteristic adverse event profile affecting the hands and feet as well as flexures.Because of a very high incidence of these reactions, adequate precautions to prevent, as well as early diagnosis and management, improve quality of life as well as outcomes of treatment.

Zitieren

APA

S, M. A. (2017). Regorafenib Induced Toxic Erythema of Chemotherapy Presenting as Malignant Intertigo with Hand Foot Skin Reaction. Clinical Dermatology Open Access Journal. https://doi.org/10.23880/cdoaj-16000134

Vancouver

S MA. Regorafenib Induced Toxic Erythema of Chemotherapy Presenting as Malignant Intertigo with Hand Foot Skin Reaction. Clinical Dermatology Open Access Journal. 2017. doi:10.23880/cdoaj-16000134

BibTeX
@article{S2017,
  author = {S, Mehta Ambalal},
  title = {Regorafenib Induced Toxic Erythema of Chemotherapy Presenting as Malignant Intertigo with Hand Foot Skin Reaction},
  journal = {Clinical Dermatology Open Access Journal},
  year = {2017},
  doi = {10.23880/cdoaj-16000134}
}
Kostenlos starten →